All research involving humans collect regulatory documentation. The collection of source documentation serves to reconstruct the study as it happened. It enables an independent observer to confirm the results. This process holds investigators accountable to the protocol and protects participants' rights and safety. Good documentation described in the FDA's data integrity and compliance guidelines is obtained in the form of ALCOA (attributable, legible, contemporaneous, original and accurate). The utilization of a regulatory binder and participant binder assists investigators and study personnel in the collection and maintenance of documentation required for the reconstruction of a study.
This eRegulatory Binder assists study sites to achieve and maintain regulatory compliance for research involving human subjects.
Each section outlines the regulatory documentation requirements, general guidance for organization and record keeping, and, when applicable, references to federal regulations and Good Clinical Practice guidelines.
There are many benefits to collecting records in an electronic format. A few of those benifits include:
The REDCap eRegulatory Binder Template provides a structure for essential record collection and retention. This template is intended for IRB approved research studies and should follow your organizations SOPs.
Guidelines for use of the binder:
For more eREG resources go to eREG at CCHMC. For more information on general regulatory requirements, go to CCTST Regulatory Knowledge and Support or the FDA.
Depending on the nature of the research, some tabs may or may not be required. Use the below list to ensure that the applicable sections are maintained.
STEP 2: Using the eRegulatory Binder
Developed by Theresa Baker